Brian Shinder

Brian Shinder practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Brian Shinder's NPI, 1023493772, was assigned on July 23, 2015. Brian Shinder graduated from Rutgers Robert Wood Johnson Medical School in 2015. Brian Shinder holds Connecticut license 78975.

Brian Shinder's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Brian Shinder's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Brian Shinder is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Brian Shinder to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Brian Shinder practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Brian Shinder's primary specialty in the NPI Registry, under taxonomy code 208800000X. Brian Shinder is licensed in Connecticut.

CMS data shows 142 Medicare services from Brian Shinder across 4 procedure codes in 2024, for 81 Medicare patients. Medicare paid $8,065 for them. Every service was in an office.

CMS counts 81 Medicare patients who saw Brian Shinder in 2024. The largest group is 75 to 84, with 35 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Brian Shinder's median patient age at 71, with 24% women.

In 2024, Brian Shinder wrote 101 Medicare Part D claims for 47 patients. 97% of them were for generic drugs. CMS names the drug for 74 of them, across 2 drugs with 11 or more claims each, at $567 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Brian Shinder for performance year 2024, reported as part of a group. Brian Shinder accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Brian Shinder as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Brian Shinder, published from 2022 to 2023. 2022 was the busiest year, with 3. The most frequent topics are Carcinoma, Renal Cell and Kidney Neoplasms. Brian Shinder has published most often in J Kidney Cancer VHL. Brian Shinder's most frequent co-authors are Tina M. Mayer, MD, Saum Bobak Ghodoussipour, MD and Mark Paul Bramwit, MD.

CMS Open Payments shows 6 general payments to Brian Shinder from 2 drug and device companies from 2021 to 2023. Travel and lodging make up the largest share, 53% of the total. Olympus Corporation of the Americas paid the most, $206.

Brian Shinder graduated from Rutgers Robert Wood Johnson Medical School in 2015.